Raphaël Leblanc

1.0k total citations
22 papers, 819 citations indexed

About

Raphaël Leblanc is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Raphaël Leblanc has authored 22 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cell Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Raphaël Leblanc's work include Sphingolipid Metabolism and Signaling (10 papers), Extracellular vesicles in disease (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Raphaël Leblanc is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Extracellular vesicles in disease (4 papers) and Hippo pathway signaling and YAP/TAZ (4 papers). Raphaël Leblanc collaborates with scholars based in France, United States and Belgium. Raphaël Leblanc's co-authors include Olivier Peyruchaud, Debashish Sahay, Marion David, Philippe Clézardin, Johnny Ribeiro, Pascale Zimmermann, Duane D. Miller, Gábor Tigyi, Derek D. Norman and Sue-Chin Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Raphaël Leblanc

21 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphaël Leblanc France 14 535 290 175 172 119 22 819
Sujatha Jagadeeswaran United States 12 465 0.9× 360 1.2× 197 1.1× 87 0.5× 100 0.8× 16 973
Mamunur Rashid United Kingdom 14 491 0.9× 248 0.9× 220 1.3× 67 0.4× 116 1.0× 19 817
Shiro Kataoka Japan 13 480 0.9× 219 0.8× 103 0.6× 77 0.4× 183 1.5× 27 717
Gerald Schmid Austria 16 578 1.1× 387 1.3× 145 0.8× 78 0.5× 65 0.5× 27 889
Yuzhen Feng China 14 462 0.9× 230 0.8× 145 0.8× 126 0.7× 100 0.8× 30 827
Colin Crean United States 13 377 0.7× 151 0.5× 104 0.6× 89 0.5× 105 0.9× 21 647
Shuangbing Xu China 21 775 1.4× 370 1.3× 317 1.8× 89 0.5× 142 1.2× 42 1.1k
Sagarika Ray United States 7 773 1.4× 198 0.7× 109 0.6× 73 0.4× 89 0.7× 7 982
Manoj M. Pillai United States 18 557 1.0× 231 0.8× 236 1.3× 34 0.2× 141 1.2× 39 897

Countries citing papers authored by Raphaël Leblanc

Since Specialization
Citations

This map shows the geographic impact of Raphaël Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Leblanc more than expected).

Fields of papers citing papers by Raphaël Leblanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Leblanc. The network helps show where Raphaël Leblanc may publish in the future.

Co-authorship network of co-authors of Raphaël Leblanc

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Leblanc. A scholar is included among the top collaborators of Raphaël Leblanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Leblanc. Raphaël Leblanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leblanc, Raphaël, Stéphane Audebert, Kim De Veirman, et al.. (2025). Syntenin inhibition impairs stroma‐tumor communication in multiple myeloma and improves bortezomib treatment efficiency. HemaSphere. 9(8). e70197–e70197.
2.
Daaboul, George G., Raphaël Leblanc, Frédérique Lembo, et al.. (2023). PDZ scaffolds regulate extracellular vesicle production, composition, and uptake. Proceedings of the National Academy of Sciences. 120(38). e2310914120–e2310914120. 11 indexed citations
3.
Leblanc, Raphaël, Rania Ghossoub, Armelle Goubard, et al.. (2023). Downregulation of stromal syntenin sustains AML development. EMBO Molecular Medicine. 15(11). e17570–e17570. 6 indexed citations
4.
Hoffer, Laurent, Raphaël Leblanc, Mikaël Feracci, et al.. (2023). Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein–Protein Interaction: A Semi-Automated “Hit Identification-to-Optimization” Approach. Journal of Medicinal Chemistry. 66(7). 4633–4658. 4 indexed citations
5.
Hoffer, Laurent, Raphaël Leblanc, Mikaël Feracci, et al.. (2021). Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread. European Journal of Medicinal Chemistry. 223. 113601–113601. 9 indexed citations
6.
Just‐Landi, Sylvaine, Joanna Fares, Raphaël Leblanc, et al.. (2021). Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia. Frontiers in Immunology. 12. 730970–730970. 15 indexed citations
7.
Ghossoub, Rania, Raphaël Leblanc, Guido David, & Pascale Zimmermann. (2021). Tétraspanines et syndécanes. médecine/sciences. 37(12). 1101–1107. 2 indexed citations
8.
Ghossoub, Rania, Stéphane Audebert, Raphaël Leblanc, et al.. (2020). Tetraspanin-6 negatively regulates exosome production. Proceedings of the National Academy of Sciences. 117(11). 5913–5922. 73 indexed citations
9.
10.
Leblanc, Raphaël, et al.. (2018). Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis. Oncotarget. 9(69). 33170–33185. 28 indexed citations
11.
Leblanc, Raphaël, et al.. (2018). Platelets, autotaxin and lysophosphatidic acid signalling: win‐win factors for cancer metastasis. British Journal of Pharmacology. 175(15). 3100–3110. 42 indexed citations
12.
Leblanc, Raphaël & Olivier Peyruchaud. (2016). Metastasis: new functional implications of platelets and megakaryocytes. Blood. 128(1). 24–31. 177 indexed citations
13.
Leblanc, Raphaël & Olivier Peyruchaud. (2016). The role of platelets and megakaryocytes in bone metastasis. Journal of bone oncology. 5(3). 109–111. 17 indexed citations
14.
Sahay, Debashish, Raphaël Leblanc, Thomas G. P. Grünewald, et al.. (2015). The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer. Oncotarget. 6(24). 20604–20620. 55 indexed citations
15.
David, Marion, Debashish Sahay, Françoise Descôtes, et al.. (2014). Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA1) Activation in Human Breast and Prostate Cancers. PLoS ONE. 9(5). e97771–e97771. 25 indexed citations
16.
Leblanc, Raphaël & Olivier Peyruchaud. (2014). New insights into the autotaxin/LPA axis in cancer development and metastasis. Experimental Cell Research. 333(2). 183–189. 83 indexed citations
17.
David, Marion, Irma Machuca‐Gayet, Junichi Kikuta, et al.. (2014). Lysophosphatidic Acid Receptor Type 1 (LPA1) Plays a Functional Role in Osteoclast Differentiation and Bone Resorption Activity. Journal of Biological Chemistry. 289(10). 6551–6564. 43 indexed citations
18.
Leblanc, Raphaël, Sue-Chin Lee, Marion David, et al.. (2014). Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood. 124(20). 3141–3150. 136 indexed citations
19.
Peyruchaud, Olivier, Raphaël Leblanc, & Marion David. (2012). Pleiotropic activity of lysophosphatidic acid in bone metastasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(1). 99–104. 27 indexed citations
20.
Kohen, Elli, et al.. (2002). Fluorescence imaging of mitochondrial responses to glucose challenge and probes in mitochondrial DNA-deficient osteosarcoma cells.. Microscopy and Microanalysis. 8(S02). 950–951. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sujatha Jagadeeswaran Breakdown of academic impact, for papers by Mamunur Rashid Breakdown of academic impact, for papers by Shiro Kataoka Breakdown of academic impact, for papers by Gerald Schmid Breakdown of academic impact, for papers by Yuzhen Feng Breakdown of academic impact, for papers by Colin Crean Breakdown of academic impact, for papers by Shuangbing Xu Breakdown of academic impact, for papers by Sagarika Ray Breakdown of academic impact, for papers by Manoj M. Pillai
Rankless by CCL
2026